Cargando…

A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need

Quantitative systems pharmacology (QSP) is a rapidly emerging discipline with application across a spectrum of challenges facing the pharmaceutical industry, including mechanistically informed prioritization of target pathways and combinations in discovery, target population, and dose expansion deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ermakov, Sergey, Schmidt, Brian J., Musante, Cynthia J., Thalhauser, Craig J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389347/
https://www.ncbi.nlm.nih.gov/pubmed/30417600
http://dx.doi.org/10.1002/psp4.12373
_version_ 1783397935983099904
author Ermakov, Sergey
Schmidt, Brian J.
Musante, Cynthia J.
Thalhauser, Craig J.
author_facet Ermakov, Sergey
Schmidt, Brian J.
Musante, Cynthia J.
Thalhauser, Craig J.
author_sort Ermakov, Sergey
collection PubMed
description Quantitative systems pharmacology (QSP) is a rapidly emerging discipline with application across a spectrum of challenges facing the pharmaceutical industry, including mechanistically informed prioritization of target pathways and combinations in discovery, target population, and dose expansion decisions early in clinical development, and analyses for regulatory authorities late in clinical development. QSP's development has influences from physiologic modeling, systems biology, physiologically‐based pharmacokinetic modeling, and pharmacometrics. Given a varied scientific heritage, a variety of tools to accomplish the demands of model development, application, and model‐based analysis of available data have been developed. We report the outcome from a community survey and resulting analysis of how modelers view the impact and growth of QSP, how they utilize existing tools, and capabilities they need improved to further accelerate their impact on drug development. These results serve as a benchmark and roadmap for advancements to the QSP tool set.
format Online
Article
Text
id pubmed-6389347
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63893472019-03-07 A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need Ermakov, Sergey Schmidt, Brian J. Musante, Cynthia J. Thalhauser, Craig J. CPT Pharmacometrics Syst Pharmacol White Paper Quantitative systems pharmacology (QSP) is a rapidly emerging discipline with application across a spectrum of challenges facing the pharmaceutical industry, including mechanistically informed prioritization of target pathways and combinations in discovery, target population, and dose expansion decisions early in clinical development, and analyses for regulatory authorities late in clinical development. QSP's development has influences from physiologic modeling, systems biology, physiologically‐based pharmacokinetic modeling, and pharmacometrics. Given a varied scientific heritage, a variety of tools to accomplish the demands of model development, application, and model‐based analysis of available data have been developed. We report the outcome from a community survey and resulting analysis of how modelers view the impact and growth of QSP, how they utilize existing tools, and capabilities they need improved to further accelerate their impact on drug development. These results serve as a benchmark and roadmap for advancements to the QSP tool set. John Wiley and Sons Inc. 2019-01-30 2019-02 /pmc/articles/PMC6389347/ /pubmed/30417600 http://dx.doi.org/10.1002/psp4.12373 Text en © 2018 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle White Paper
Ermakov, Sergey
Schmidt, Brian J.
Musante, Cynthia J.
Thalhauser, Craig J.
A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
title A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
title_full A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
title_fullStr A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
title_full_unstemmed A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
title_short A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
title_sort survey of software tool utilization and capabilities for quantitative systems pharmacology: what we have and what we need
topic White Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389347/
https://www.ncbi.nlm.nih.gov/pubmed/30417600
http://dx.doi.org/10.1002/psp4.12373
work_keys_str_mv AT ermakovsergey asurveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT schmidtbrianj asurveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT musantecynthiaj asurveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT thalhausercraigj asurveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT ermakovsergey surveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT schmidtbrianj surveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT musantecynthiaj surveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed
AT thalhausercraigj surveyofsoftwaretoolutilizationandcapabilitiesforquantitativesystemspharmacologywhatwehaveandwhatweneed